Biotechnology in healthcare. Volume 2, Applications and regulatory issues /
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
London, UK :
Academic Press,
[2022]
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Front Cover
- Biotechnology in Healthcare, Volume 2
- Biotechnology in Healthcare, Volume 2: Applications and Initiatives
- Copyright
- Dedication
- Contents
- Contributors
- About editor
- Preface
- 1
- Applications of biotechnology in healthcare
- 1
- Biotechnology in primary healthcare and hospital management
- 1. Introduction
- 2. Primary healthcare and its importance: current status in India
- 3. Biotechnology applications in primary healthcare
- 3.1 Diagnosis
- 3.2 Treatment
- 3.3 Preventives
- 3.4 Family planning and family medicine
- 4. Biotechnology in hospital management
- 4.1 Sterilization and operation theater
- 4.2 Rapid and mass molecular diagnosis
- 4.2.1 Genetic diseases, disorders, and molecular diagnosis
- 4.3 Targeted therapy
- 4.3.1 Prostate carcinoma and targeted therapy
- 4.3.2 Breast cancer and targeted therapy
- 4.3.3 Lung cancer and targeted therapy
- 4.4 Probiotic and biome replacement therapy
- 4.5 In transfusion medicine
- 5. Biotechnology-based biosafety
- 6. Challenges and future prospects
- Acknowledgments
- References
- 2
- Biotechnology in public and rural health
- 1. Introduction
- 2. Biotechnology approaches to improve public and rural health
- 2.1 Vaccines and delivery of vaccines
- 2.2 Nutrients enriched genetically modified food
- 2.3 Reduced food toxins and allergens
- 2.4 Life-saving vaccines
- 3. Advanced biotechnological achievements applied in rural areas
- 4. Environmental biotechnology applied to public and rural health
- 5. Future prospects
- References
- 3
- Invertebrate models in translational research: lessons from Caenorhabditis elegans and Drosophila melanogaster
- 1. Introduction
- 2. Caenorhabditis elegans models for translational research
- 2.1 Aging
- 2.2 Cancer
- 2.3 Rare human disease
- 2.4 Neurological and movement disorders
- 2.4.1 Alzheimer disease
- 2.4.2 Parkinson disease
- 2.4.3 Amyotrophic lateral sclerosis
- 2.5 Obesity
- 3. Drosophila models for translational research
- 3.1 Aging
- 3.2 Cancer
- 3.3 Modeling rare human diseases
- 3.4 Neurological and movement disorders
- 3.4.1 Alzheimer disease
- 3.4.2 Parkinson disease
- 3.4.3 Amyotrophic lateral sclerosis
- 3.5 Obesity
- 4. Translational impact of invertebrate research
- Glossary
- Acknowledgments
- References
- 4
- Biotechnology for diagnosis, prognosis, and monitoring cancer
- 1. Introduction
- 1.1 Limitations and advantages of tissue biopsy
- 1.2 Limitations and advantages of liquid biopsy
- 2. Types of liquid biopsy specimens
- 2.1 Circulating tumor cells
- 2.1.1 Preanalytical considerations
- 2.2 Extracellular vesicles (exosomes)
- 2.2.1 Preanalytical considerations
- 2.3 Circulating RNAs
- 2.3.1 Preanalytical considerations
- 2.4 Circulating free DNA
- 2.4.1 Preanalytical considerations
- 3. Chemical modifications to increase sensitivity in mutant detection
- 3.1 LNA-PCR
- 3.2 PNA-PCR